ASSOCIATE Professor Parisa Aslani (pictured) from the University of Sydney’s Faculty of Pharmacy has been named as the recipient of the 2013 Royal Pharmaceutical Society’s Pharmacy Research UK Award. Aslani’s award is recognition of her international reputation as an expert in her fields of research which include Consumer Medicine Information (CMI) and adherence to therapy. “The prestigious honour awards individuals who demonstrate leadership and make a significant contribution to the field of pharmacy practice research,” according to a statement from the university, where Associate Professor Aslani is the current holder of the Thompson Fellowship. Her research in CMI has attracted several significant grants in recent years, and fostered several collaborations with academics from the US and Europe as well as with other Australian universities. Aslani is currently conducting research to develop and evaluate useable patient medicine information documents to meet consumer needs and ensure optimal delivery by healthcare professionals. She will travel to the UK in September to accept the award and present a lecture on her work. Pharmacy Research UK Board of Trustees chair, Professor Anthony Smith, said Associate Professor Aslani was a deserving recipient. “Her research focus shows an ambition to improve healthcare for the benefit of patients which is at the heart of our aspirations for Pharmacy Research UK,” he said.
HIGH rates of unnecessary prescribing reported in the Australian Institute of Health and Welfare (AIHW) Australia’s Health 2018 report highlights the need for greater integration of pharmacists in medication management roles, the Pharmaceutical Society of Australia (PSA) believes.